These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12448047)

  • 1. Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():409-10. PubMed ID: 12448047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Estrogen replacement therapy and breast cancer].
    Bakken K; Alsaker E; Eggen AE; Lund E
    Tidsskr Nor Laegeforen; 2005 Feb; 125(3):282-5. PubMed ID: 15702147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen replacement therapy and ovarian cancer.
    Folsom AR; Anderson JP; Ross JA
    Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapies and ovarian cancer].
    Grenman S; Salmi T
    Duodecim; 2002; 118(4):349-56. PubMed ID: 12233039
    [No Abstract]   [Full Text] [Related]  

  • 6. An analysis of ovarian cancer in the Million Women Study.
    Neves-E-Castro M
    Gynecol Endocrinol; 2007 Jul; 23(7):410-3. PubMed ID: 17701773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmenopausal hormone therapy--an update. Benefit versus risk--important to identify women with increased breast cancer risk].
    von Schoultz B
    Lakartidningen; 2009 Aug 19-25; 106(34):2041-2. PubMed ID: 19769143
    [No Abstract]   [Full Text] [Related]  

  • 8. Hormone replacement therapy and ovarian cancer risk: a meta-analysis.
    Zhou B; Sun Q; Cong R; Gu H; Tang N; Yang L; Wang B
    Gynecol Oncol; 2008 Mar; 108(3):641-51. PubMed ID: 18221779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone hazards. Long-term estrogen use may double the risk of ovarian cancer. But look beyond the numbers.
    Gorman C
    Time; 2001 Apr; 157(13):78. PubMed ID: 11299712
    [No Abstract]   [Full Text] [Related]  

  • 10. Does HRT promote ovarian cancer?
    Health News; 2001 May; 7(5):8. PubMed ID: 11851163
    [No Abstract]   [Full Text] [Related]  

  • 11. Estrogen-progestogen replacement therapy and ovarian cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Dec; 15(6):490-2. PubMed ID: 17106327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T
    Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
    Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
    J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and invasive and borderline epithelial ovarian cancer risk.
    Mills PK; Riordan DG; Cress RD; Goldsmith DF
    Cancer Detect Prev; 2005; 29(2):124-32. PubMed ID: 15829372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
    Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
    Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statement on results of the HERS II trial on hormone replacement therapy.
    American College of Obstetricians and Gynecologists
    Ginecol Obstet Mex; 2002 Aug; 70():406-8. PubMed ID: 12448046
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M; Koera K; Nagata H; Nakano H
    J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy in women with systemic lupus erythematosus and risk of cardiovascular disease.
    Hochman J; Urowitz MB; Ibañez D; Gladman DD
    Lupus; 2009 Apr; 18(4):313-7. PubMed ID: 19276299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.